MJFF awards $6m to Lario Therapeutics for Parkinson’s research
The neurological disease is estimated to affect more than ten million people globally
Read More
Tag: Parkinson’s disease
Study finds Parkinson’s disease SLT more effective than one used in NHS
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
Mission awarded $5.2m to advance potential Parkinson’s treatment
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
Herantis Pharma granted €3.6m to assess treatment for Parkinson’s disease
In the UK, the progressive neurodegenerative condition affects around 153,000 people
Read More
Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
The neurodegenerative condition currently affects around 153,000 people in the UK
Read More
US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
The progressive neurodegenerative condition affects more than ten million people worldwide
Read More
LucyTx announces additional $12.5m research funding for neurological diseases
Alzheimer’s and Parkinson’s disease are responsible for more than 30 million cases globally
Read More
Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
The progressive neurological condition affects more than six million people worldwide
Read More
Researchers reveal people with Parkinson’s more likely to experience delirium in hospital
Two out of three people with the neurodegenerative condition experienced delirium in hospital
Read More
Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
Read More
Roche partners with Cardiff researchers to uncover new research into dementia
Affecting 55 million people globally, dementia impairs the ability to remember, think or make decisions
Read More
AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland
The progressive neurological disorder affects approximately 12,400 people in Scotland
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
